340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Court Ruling Might Put Some Hospitals’ 340B Status in Jeopardy

Dispute over where Medicare managed care belongs in the DSH calculation.
 

Print Article

September 27, 2011—A recent federal appeals court ruling on how Medicare managed care beneficiaries should be factored into a hospital’s Medicare disproportionate share (DSH) patient percentage could potentially lead to hospitals being terminated from the 340B drug discount program—particularly in states with high Medicare managed care utilization.

In Northeast Hospital Corp. v. Sebelius, the U.S. District of Columbia Circuit Court of Appeals was asked to decide whether the Centers for Medicare and Medicaid Services (CMS) had the authority to include Medicare+Choice (M+C) patient days in the Supplemental Security Income (SSI)/Medicare fraction of a hospital’s DSH patient percentage. The M+C program is now called Medicare Advantage.

The DSH patient percentage, a proxy for the number of low-income patients that a hospital serves, is the sum of a hospital’s SSI/Medicare fraction and Medicaid fraction. Adding M+C days to the SSI/Medicare fraction usually lowers a hospital’s DSH patient percentage. The DSH patient percentage is used to calculate the DSH payment percentage, which determines 340B eligibility. To participate in 340B, public, private nonprofit, children’s and free-standing cancer hospitals must have a DSH payment percentage greater than 11.75 percent. For rural referral centers and sole community hospitals, the threshold is 8 percent. There is no DSH requirement for critical access hospitals.

The Northeast case involves a Massachusetts hospital’s contention that CMS’s decision to include M+C days in its SSI/Medicare fraction for fiscal years 1999-2002 was improper and reduced its Medicare payments by nearly $750,000.

In 2004, CMS issued a regulation stating that it was its policy to count M+C days in the SSI/Medicare fraction. In the lawsuit, it argued that prior to 2004 it had an unwritten policy of including the days in the SSI/Medicare fraction.

The hospital contended that, under the Medicare statute, CMS had no right in any year to include the days in the SSI/Medicare fraction. In its Sept. 13 decision, the appeals court disagreed, stating that the statute can be construed to allow inclusion of M+C days in the SSI/Medicare fraction from 2004 forward. But, it added, including M+C days for periods prior to 2004 is impermissible retroactive rulemaking.

During the summer of 2009, the Health Resources and Services Administration notified about 50 hospitals enrolled in 340B that they would be terminated from the program because they had fallen below the DSH eligibility threshold based on SSI/Medicare percentages for 2007, which included Medicare managed care days. The notices were sent shortly after CMS published and then subsequently withdrew those percentages. The hospitals were granted permission to stay in the 340B program because the 2007 percentages were in question.

Many observers believe that CMS delayed issuing final SSI/Medicare percentages for 2007 and subsequent years because it was awaiting the outcome in the Northeast case. They say hospitals should expect CMS to update the SSI/Medicare percentages soon.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
2 Aug

We are five months away from Medicare price caps taking effect for 10 top-selling drugs under the #IRA. Our latest #340BInsight episode discusses how this will affect covered entities and provides an updated calculator that 340B Health members can use to estimate the price cap…

Reply on Twitter 1951664033473745025 Retweet on Twitter 1951664033473745025 Like on Twitter 1951664033473745025 Twitter 1951664033473745025
340bhealth 340B Health @340bhealth ·
1 Aug

A limited pilot program announced by @HRSAgov would allow some drugmakers to replace upfront #340B discounts with backend rebates. More: http://bit.ly/4ofrSzl.
The program would apply only to the first 10 Medicare drugs subject to price caps in 2026, but HRSA might expand the…

Reply on Twitter 1951305643962355953 Retweet on Twitter 1951305643962355953 Like on Twitter 1951305643962355953 Twitter 1951305643962355953
340bhealth 340B Health @340bhealth ·
28 Jul

Missouri’s law preventing and penalizing drugmaker conditions on pharmacy partnerships can stay in effect, according to a federal judge who dismissed @AbbVie’s petition to halt enforcement of the law.

This is the latest in a series of decisions that uphold upholding such…

Reply on Twitter 1949859205805985915 Retweet on Twitter 1949859205805985915 Like on Twitter 1949859205805985915 Twitter 1949859205805985915
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health